Today, the Honourable Anita Anand, Minister of Public Services and Procurement, announced that Canada has entered into an agreement with Moderna for additional supply of its COVID-19 vaccine for 2022 and 2023, with an option to extend into 2024.

“Our government is continuing to work with leading vaccine developers in order to ensure that Canadians have ongoing access to a diverse portfolio of vaccines. This agreement will help to bridge Canada’s capacity to maintain a reliable and rapidly available supply of vaccines into 2022 and 2023 ahead of Moderna’s Canadian vaccine facility becoming operational.”

The Honourable Anita Anand
Minister of Public Services and Procurement 

• As part of this agreement :

  • Canada has secured access to a guaranteed 20 million doses of COVID-19 vaccines for 2022, with options for up to 15 million more
  • For 2023, Canada has secured access to a guaranteed 20 million doses, with options for up to 15 million more
  • 2024 is an option year. If this option is exercised, Canada will have access to another 35 million doses

• On behalf of the Public Health Agency of Canada, and based on advice from the COVID-19 Vaccine Task Force, Public Services and Procurement Canada is leading negotiations and finalizing agreements with suppliers of COVID-19 vaccine candidates

• The Moderna COVID-19 mRNA vaccine is used to protect against COVID-19. The Moderna COVID-19 vaccine was authorized for use by Health Canada on December 23, 2020, for adults aged 18 and older. On June 7, 2021, Moderna submitted an application to Health Canada for authorization of its COVID-19 vaccine for use in adolescents aged 12 and older

Associated links

• Coronavirus disease (COVID-19): Canada’s response
• Procuring vaccines for COVID-19
• Supplying Canada’s response to COVID-19

Cecely Roy
Press Secretary
Office of the Honourable Anita Anand
343-549-7293
cecely.roy@canada.ca

Media Relations
Public Services and Procurement Canada
819-420-5501
media@pwgsc-tpsgc.gc.ca

Follow us on Twitter

Follow us on Facebook